Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Maria Karakosta & Kalliopi N. Manola. (2016) The parallel application of karyotype interphase and metaphase FISH after DSP-30/IL-2 stimulation is necessary for the investigation of chronic lymphocytic leukemia. Hematology 21:9, pages 526-535.
Read now
Read now
Lizalynn M. Dias, Venkata Thodima, Julia Friedman, Charles Ma, Asha Guttapalli, Geetu Mendiratta, Imran N. Siddiqi, Sergei Syrbu, R. S. K. Chaganti & Jane Houldsworth. (2016) Cross-platform assessment of genomic imbalance confirms the clinical relevance of genomic complexity and reveals loci with potential pathogenic roles in diffuse large B-cell lymphoma. Leukemia & Lymphoma 57:4, pages 899-908.
Read now
Read now
Articles from other publishers (24)
Ludovic Jondreville, Lea Dehgane, Cecile Doualle, Luce Smagghe, Beatrice Grange, Frederic Davi, Leticia K. Lerner, Delphine Garnier, Clotilde Bravetti, Olivier Tournilhac, Damien Roos-Weil, Marouane Boubaya, Elise Chapiro, Santos A. Susin & Florence Nguyen-Khac. (2023) del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemia. Leukemia 37:11, pages 2221-2230.
Crossref
Crossref
Florence Nguyen-Khac, Zsofia Balogh, Jasmine Chauzeix, Lauren Veronese & Elise Chapiro. (2023) Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH). Current Research in Translational Medicine 71:4, pages 103410.
Crossref
Crossref
Michele Cennamo, Davide Sirocchi, Carolina Giudici, Marzia Giagnacovo, Guido Petracco, Daniela Ferrario, Simona Garganigo, Angela Papa, Emanuela Veniani, Alessandro Squizzato, Lucia Del Vecchio, Carlo Patriarca, Michelarcangelo Partenope & Piergiorgio Modena. (2023) A Peculiar CLL Case with Complex Chromosome 6 Rearrangements and Refinement of All Breakpoints at the Gene Level by Genomic Array: A Case Report. Journal of Clinical Medicine 12:12, pages 4110.
Crossref
Crossref
Andriana Valkama, Sandra Vorimo, Timo A. Kumpula, Hannele Räsänen, Eeva-Riitta Savolainen, Katri Pylkäs & Tuomo Mantere. (2023) Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia. Cancers 15:4, pages 1294.
Crossref
Crossref
Eva Ondroušková, Michaela Bohúnová, Kristýna Závacká, Patrik Čech, Petra Šmuhařová, Miroslav Boudný, Martina Oršulová, Anna Panovská, Lenka Radová, Michael Doubek, Karla Plevová & Marie Jarošová. (2022) Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations. Frontiers in Oncology 12.
Crossref
Crossref
Florence Nguyen-Khac. (2022) “Double-Hit” Chronic Lymphocytic Leukemia, Involving the TP53 and MYC Genes. Frontiers in Oncology 11.
Crossref
Crossref
Beyhan Durak Aras, Sevgi Isik, Hava Uskudar Teke, Abdulvahap Aslan, Filiz Yavasoglu, Zafer Gulbas, Fatih Demirkan, Hulya Ozen, Oguz Cilingir, Nur Sena Inci, Gulcin Gunden, Tuba Bulduk, Ebru Erzurumluoglu Gokalp, Sinem Kocagil, Sevilhan Artan & Olga Meltem Akay. (2021) Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?. Molecular Cytogenetics 14:1.
Crossref
Crossref
Zhenya Tang, Rashmi Kanagal-Shamanna, Guilin Tang, Keyur Patel, L. Jeffrey Medeiros & Gokce A. Toruner. (2021) Analytical and clinical performance of chromosomal microarrays compared with FISH panel and conventional karyotyping in patients with chronic lymphocytic leukemia. Leukemia Research 108, pages 106616.
Crossref
Crossref
Sevgi Isik, Gulcin Gunden, Eren Gunduz, Olga Meltem Akay, Abdulvahap Aslan, Hulya Ozen, Oguz Cilingir, Ebru Erzurumluoglu Gokalp, Sinem Kocagil, Sevilhan Artan, Zafer Gulbas & Beyhan Durak Aras. (2021) An Anomaly with Potential as a New Prognostic Marker in CLL with del(13q): Gain of 16p13.3. Cytogenetic and Genome Research 161:10-11, pages 479-487.
Crossref
Crossref
Yi Ding. 2021. Practical Oncologic Molecular Pathology. Practical Oncologic Molecular Pathology
339
359
.
Martina Ghetti, Ivan Vannini, Clelia Tiziana Storlazzi, Giovanni Martinelli & Giorgia Simonetti. (2020) Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin. Molecular Cancer 19:1.
Crossref
Crossref
Jimmy Lee & Y. Lynn Wang. (2020) Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia. The Journal of Molecular Diagnostics 22:9, pages 1114-1125.
Crossref
Crossref
Nina Kreuzberger, Johanna AAG Damen, Marialena Trivella, Lise J Estcourt, Angela Aldin, Lisa Umlauff, Maria DLA Vazquez-Montes, Robert Wolff, Karel GM Moons, Ina Monsef, Farid Foroutan, Karl-Anton Kreuzer & Nicole Skoetz. (2020) Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis. Cochrane Database of Systematic Reviews 2020:7.
Crossref
Crossref
Yen-Chun Liu, Elizabeth Margolskee, John N. Allan, Susan Mathew, Erica Bhavsar, Joseph Casano, Attilio Orazi, Richard R. Furman & Julia T. Geyer. (2020) Chronic lymphocytic leukemia with TP53 gene alterations: a detailed clinicopathologic analysis. Modern Pathology 33:3, pages 344-353.
Crossref
Crossref
Kathy Chun, Gail D. Wenger, Alka Chaubey, D.P. Dash, Rashmi Kanagal-Shamanna, Sibel Kantarci, Ravindra Kolhe, Daniel L. Van Dyke, Lu Wang, Daynna J. Wolff & Patricia M. Miron. (2018) Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia. Cancer Genetics 228-229, pages 236-250.
Crossref
Crossref
Lei Yang, Di Wu, Jinbin Chen, Jiansong Chen, Fuman Qiu, Yinyan Li, Li Liu, Yi Cao, Binyao Yang, Yifeng Zhou & Jiachun Lu. (2018) A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese. Carcinogenesis 39:3, pages 347-359.
Crossref
Crossref
Elise Chapiro, Claude Lesty, Clémentine Gabillaud, Eric Durot, Simon Bouzy, Marine Armand, Magali Le Garff-Tavernier, Nadia Bougacha, Stéphanie Struski, Audrey Bidet, Elodie Laharanne, Carole Barin, Lauren Veronese, Nolwen Prié, Virginie Eclache, Baptiste Gaillard, Lucienne Michaux, Christine Lefebvre, Jean-Baptiste Gaillard, Christine Terré, Dominique Penther, Christian Bastard, Nathalie Nadal, Sandra Fert-Ferrer, Nathalie Auger, Catherine Godon, Laurent Sutton, Olivier Tournilhac, Santos A. Susin & Florence Nguyen-Khac. (2018) “Double-hit” chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain. American Journal of Hematology 93:3, pages 375-382.
Crossref
Crossref
Sabah Kadri, Jimmy Lee, Carrie Fitzpatrick, Natalie Galanina, Madina Sukhanova, Girish Venkataraman, Shruti SharmaBrad Long, Kristin PetrasMegan TheissenMei MingYuri KobzevWenjun Kang, Ailin GuoWeige WangNifang NiuHoward Weiner, Michael Thirman, Wendy Stock, Sonali M. Smith, Chadi Nabhan, Jeremy P. SegalPin LuY. Lynn Wang. (2017) Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL. Blood Advances 1:12, pages 715-727.
Crossref
Crossref
Małgorzata Rogalińska, Paweł Góralski, Jerzy Z. Błoński, Paweł Robak, Jan Barciszewski, Aneta Koceva-Chyła, Henryk Piekarski, Tadeusz Robak & Zofia M. Kilianska. (2017) Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development. Oncology Letters 13:4, pages 2079-2084.
Crossref
Crossref
Imran N Siddiqi, Julia Friedman, Keegan Q Barry-Holson, Charles Ma, Venkata Thodima, Irene Kang, Raghavendra Padmanabhan, Lizalynn M Dias, Kevin R Kelly, Russell K Brynes, Sitharthan Kamalakaran & Jane Houldsworth. (2016) Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations. Modern Pathology 29:6, pages 570-581.
Crossref
Crossref
Jacqueline Schoumans, Javier Suela, Ros Hastings, Dominique Muehlematter, Katrina Rack, Eva van den Berg, H. Berna Beverloo & Marian Stevens-Kroef. (2016) Guidelines for genomic array analysis in acquired haematological neoplastic disorders. Genes, Chromosomes and Cancer 55:5, pages 480-491.
Crossref
Crossref
Sameer A. Parikh, Paolo Strati, Mazie Tsang, Colin P. West & Tait D. Shanafelt. (2016) Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysis. Blood 127:14, pages 1752-1760.
Crossref
Crossref
Susan M. O'BrienNicole LamannaThomas J. KippsIan FlinnAndrew D. ZelenetzJan A. BurgerMichael KeatingSiddhartha Mitra, Leanne Holes, Albert S. Yu, David M. Johnson, Langdon L. Miller, Yeonhee Kim, Roger D. Dansey, Ronald L. Dubowy & Steven E. Coutre. (2015) A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia. Blood 126:25, pages 2686-2694.
Crossref
Crossref
Itziar Salaverria, David Martín‐Garcia, Cristina López, Guillem Clot, Manel García‐Aragonés, Alba Navarro, Julio Delgado, Tycho Baumann, Magda Pinyol, Idoia Martin‐Guerrero, Ana Carrió, Dolors Costa, Ana C. Queirós, Sandrine Jayne, Marta Aymerich, Neus Villamor, Dolors Colomer, Marcos González, Armando López‐Guillermo, Elías Campo, Martin J. S. Dyer, Reiner Siebert, Lluís Armengol & Sílvia Beà. (2015) Detection of chromothripsis‐like patterns with a custom array platform for chronic lymphocytic leukemia. Genes, Chromosomes and Cancer 54:11, pages 668-680.
Crossref
Crossref